152 related articles for article (PubMed ID: 2846023)
1. Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
Yoneda S; Fujisawa M; Watanabe J; Okabe T; Takaku F; Homma T; Yoshida K
Br J Cancer; 1988 Sep; 58(3):292-5. PubMed ID: 2846023
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3.
Kwa HB; Verhoeven AH; Storm J; van Zandwijk N; Mooi WJ; Hilkens J
Cancer Immunol Immunother; 1995 Sep; 41(3):169-74. PubMed ID: 7553686
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
4. Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody.
Smith A; Waibel R; Stahel RA
Br J Cancer; 1991 Aug; 64(2):263-6. PubMed ID: 1654073
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
6. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
[TBL] [Abstract][Full Text] [Related]
8. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Stein R; Chen S; Haim S; Goldenberg DM
Cancer; 1997 Dec; 80(12 Suppl):2636-41. PubMed ID: 9406718
[TBL] [Abstract][Full Text] [Related]
9. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.
Beaumier PL; Venkatesan P; Vanderheyden JL; Burgua WD; Kunz LL; Fritzberg AR; Abrams PG; Morgan AC
Cancer Res; 1991 Jan; 51(2):676-81. PubMed ID: 1845957
[TBL] [Abstract][Full Text] [Related]
10. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
Fujisawa M; Okabe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
[TBL] [Abstract][Full Text] [Related]
11. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
Stein R; Goldenberg DM; Thorpe SR; Mattes MJ
J Nucl Med; 1997 Mar; 38(3):391-5. PubMed ID: 9074526
[TBL] [Abstract][Full Text] [Related]
12. Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine.
Stein R; Govindan SV; Chen S; Reed L; Spiegelman H; Griffiths GL; Hansen HJ; Goldenberg DM
Crit Rev Oncol Hematol; 2001; 39(1-2):173-80. PubMed ID: 11418314
[TBL] [Abstract][Full Text] [Related]
13. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
14. Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue.
Hosono M; Endo K; Hosono MN; Kobayashi H; Shirato M; Sakahara H; Ueda R; Konishi J
J Nucl Med; 1994 Feb; 35(2):296-300. PubMed ID: 8295002
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
Saiful Alam AF
Br J Cancer; 1991 Apr; 63(4):503-7. PubMed ID: 2021533
[TBL] [Abstract][Full Text] [Related]
17. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
[TBL] [Abstract][Full Text] [Related]
19. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
Ceriani RL; Blank EW
Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
[TBL] [Abstract][Full Text] [Related]
20. Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicin.
Desrues B; Brichory F; Léna H; Bourguet P; Delaval P; Toujas L; Dazord L
Cancer Immunol Immunother; 1996 Dec; 43(5):269-74. PubMed ID: 9024503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]